Boston Scientific (BSX) Operating Expenses (2009 - 2026)

Boston Scientific has disclosed Operating Expenses across 18 years of filings, most recently posting $2.5 billion for Q1 2026.

• Operating Expenses for Q1 2026 came in at $2.5 billion, up 9.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 billion (up 13.74% YoY), and the FY2025 annual result was $10.2 billion, up 15.24% from the prior year.
• Operating Expenses came in at $2.5 billion for Q1 2026 at Boston Scientific, down from $2.9 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q4 2025 to a low of $1.6 billion in Q1 2022.
• The 5-year median for Operating Expenses is $2.0 billion (2023), against an average of $2.1 billion.
• Across the five-year window, Operating Expenses slipped 7.34% in 2022 and gained 24.87% in 2024, its largest moves.
• Boston Scientific's Operating Expenses stood at $1.8 billion in 2022, then grew by 9.02% to $2.0 billion in 2023, then climbed by 21.3% to $2.4 billion in 2024, then increased by 17.93% to $2.9 billion in 2025, then dropped by 11.95% to $2.5 billion in 2026.
• The last three Operating Expenses figures came in at $2.5 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.5 billion (Q3 2025), per Business Quant data.